Prophylaxis of thromboembolic disease in hip and knee surgery;Profilaxis de la enfermedad tromboembólica en la cirugía de cadera y rodilla

Revista de Ortopedia y Traumatologia

Volumn 45, Issue 2, 2001, Pages 137-143

  Gil Garay, E ^a  

^a HRT La Paz planta 1   (Spain)

Author keywords

Hip arthroplasty; Knee arthroplasty; Lower limb fractures; Spinal; Thromboembolic venous disease (TEVD), TEVD prophylaxis

Indexed keywords

HIP ARTHROPLASTY; HIP SURGERY; INCIDENCE; KNEE ARTHROPLASTY; KNEE SURGERY; REVIEW; SPINAL ANESTHESIA; TECHNIQUE; THROMBOEMBOLISM;

EID: 0034975592     PISSN: 04825985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Warfarin prophylaxis to prevent mortality from pulmonary embolism after total hip replacement
2. Incidence in fatal pulmonary embolism after 1390 knee arthroplasties without routine prophylactic anticoagulation, except in high-risk cases
3. Collaborative overview of randomised trials of antiplatelet therapy, III: Reduction in venous thrombosis and pulomonary embolism by antiplatelet prophylaxis among surgical and medical patients
4. Low-molecular-weight heparin (Enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
5. The cost-effectiveness of prevention of post-operative thromboembolism
6. Low molecular weight heparin for thromboprophylaxis and epidural/spinal anaesthesia: Is there a risk?
7. New approaches to prevention of deep vein thrombosis
8. Graded compression stockings in lower limb arthroplasty. (Comunicación Congreso EFORT 1999, Bruselas)
9. Prevention of deep-vein thrombosis after total knee replacement. Randomised comparison between a low-molecular-weight heparin (Nadroparin) and mechanical prophylaxis with a foot-pump system
10. The effectiveness of intermittent plantar venous compression in prevention of deep venous thrombosis after total hip arthroplasty
11. Prevention of venous thromboembolism
12. Screening for deep-vein thrombosis after hip and knee replacement without prophylaxis
13. Thrombophlebitis after knee surgery
14. Enoxaparin clinical trial group: Use of enoxaparin, a low-molecular-weight heparin, and unfractioned heparin for prevention of deep venous thrombosis after elective hip replacement. A clinical trial comparing efficacy and safety
15. Comparison of enoxaparin and warfarin for the prevention of venous thromboembolic disease after total hip arthroplasty. Evaluation during hospitalization and three months after discharge
16. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomised trials in General, Orthopaedic and Urologic Surgery
17. Prolonged thromboprophylaxis following hip replacement surgery. Results of a double-blind, prospective, randomised, placebo-controlled study with Dalteparin (Fragmin)
18. Neurological complications after anaesthesia. A follow-up of 18.000 spinal or epidural anaesthetics performed over three years
19. Deep-vein thrombosis after total hip replacement. A comparison between spinal and general anaesthesia
20. Coste-efectividad de una heparina de bajo peso molecular en la profilaxis prolongada de la trombosis venosa profunda tras la artroplastia de cadera
21. Prevention of thromboembolism with use of recombinant Hirudin. Results of a double-blind, multicenter trial comparing the efficacy of Desirudin (Revasc) with that of unfractioned heparin in patients having a total hip replacement
22. A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement
23. Prevention of venous thromboembolism
24. Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses
25. A venous foot pump reduces thrombosis after total hip replacement
26. Comparison of warfarin and external pneumatic compression in prevention of venous thrombosis after total hip replacement
27. Venous thrombosis after elective hip replacement. The influence of preventive intermittent calf compression and of surgical technique
28. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma
29. Enfermedad tromboembólica en cirugía ortopédica y traumatología
30. Venous thromboembolic disease after hip surgery. Risk factors, prophylaxis and diagnosis
31. Cyclic sequential compression of the lower limb in prevention of deep venous thrombosis
32. Effects of extradural Bupivacaine on the haemostatic system
33. Efficacy of prophylaxis against thromboembolism with intermittent pneumatic compression after primary and revision total hip arthroplasty
34. Low molecular weight heparin: Biochemistry, Pharmacology, perioperative prophylaxis regimens, and guidelines for regional anesthetic management
35. Prophylaxis of venous thromboembolic disease following hip and knee surgery
36. A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation
37. Preoperative versus postoperative initiation of low molecular weight heparin prophylaxis against thromboembolism in patients undergoing elective hip replacement
38. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement
39. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: A one to six-year follow-up
40. A comparative, double-blind, randomised trial of a new second generation LMWH (Bemiparin) and UFH in the prevention of post-operative venous thromboembolism in patients undergoing hip arthroplasty
41. The incidence of fatal pulmonary embolism after knee replacement with no prophylactic anticoagulation
42. Thromboprophylaxis with low-molecular-weight heparin in outpatients with plaster-cast immobilisation of the leg
43. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (Dalteparin) after total hip arthroplasty. Thje Danish prolonged prophylaxis (DaPP) study
44. Prevention of venous thromboembolism after knee arthroplasty. A randomized, double-blind trial comparing enoxaparin with warfarin
45. Low molecular weight heparin in prevention of perioperative thrombosis
46. Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement
47. The efficacy of prophylaxis with low-dose warfarin for prevention of pulmonary embolism following total hip arthroplasty
48. FDA Public Health advisory
49. Deep-vein thrombosis and continuous passive motion after total knee arthroplasty
50. Venous thromboembolism and orthopaedic surgery
51. Total hip replacement, lower limb blood flow and venous thrombogenesis
52. EMRO1: Prophylaxis of thromboembolic disease with O-11 (Rovi), during abdominal surgery
53. Thromboprophylaxis and death after total hip replacement
54. Prevention of venous thromboembolism (Consensus Statement)
55. Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: A meta-analysis
56. Cost-effectiveness of prophylaxis in total hip replacement
57. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomised comparison of enoxaparin versus placebo
58. Prevention of deep vein thrombosis after total hip replacement. The effect of low molecular weight heparin with spinal and general anaesthesia
59. The long-term clinical course of acute deep-venous thrombosis
60. RD heparin compared with warfarin for prevention of venous thromboembolism disease following total hip or knee arthroplasty
61. Pathogenesis and pathophysiology of the post-thrombotic syndrome: Clinical implications
62. Prevention of venous thromboembolism in orthopaedic patients
63. Low molecular weight heparins: Mode of action and dosage
64. Prophylaxis against deep-vein thrombosis in total hip replacement. Comparison of heparin and foot-impulse pump
65. Throboembolic complications after arthrocopic knee surgery. Incidence and risk factors in 101 patients
66. The natural history and aetiology of deep vein thrombosis after total hip replacement
67. Low molecular weight heparin for the prevention of thromboembolism in outpatients immobilized by plaster cast
68. The A-V impulse system reduces deep-vein thrombosis and swelling after hemiarthroplasty for hip fracture
69. Deep vein thrombosis after elective knee surgery. An incidence study in 312 patients
70. Deep-vein thrombosis following total knee replacement
71. Randomized study of adjusted versus fixed low dose heparin prophylaxis of deep vein thrombosis in hip surgery
72. Spinal and general anaesthesia in total hip replacement: Frequency of deep vein thrombosis
73. Incidence of posthospitalization proximal deep vein thrombosis after total hip arthroplasty. A pilot study
74. Low-molecular-weight heparin: From the bench to the orthopaedic patient
75. A randomized controlled trial of a low-molecular-weight heparin (Enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery
76. Anticoagulants and spinal-epidural anesthesia
77. Does total hip arthroplasty predispose to chronic venous insufficiency?
78. Death and thromboembolic disease after total hip replacement. A series of 1162 cases with no routine chemical prophylaxis
79. Effects of intermittent pneumatic calf compression on postoperative thrombosis and plasmin activity
80. Prophylaxis against deep venous thrombosis after total knee arthroplasty: Pneumatic plantar compression and aspirin compared with aspirin alone
81. Thromboembolic prophylaxis in total knee replacement. Evaluation of the A-V impulse system
82. Incidence of deep vein thrombosis after arthrocopic knee surgery: A prospective study
83. Intermittent pneumatic compression to prevent proximal deep venous thrombosis during and after total hip replacement. A prospective, randomized study of compression alone, compression and aspirin and compression and low-dose warfarin